Relationship of group B <i>streptococcus</i> colonization in late pregnancy with perinatal outcomes

doi:10.3785/j.issn.1008-9292.2020.04.12

J Zhejiang Univ (Med Sci)

2020, Vol. 49

Issue (3): 389-396 DOI: 10.3785/j.issn.1008-9292.2020.04.12

Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes

YANG Lindong¹(

),BAO Fang^1,²,WU Yuanzhe¹,SUN Lizhou^3,*(

)

1. Department of Obstetrics and Gynecology, General Hospital of PLA Eastern Theater Command, Nanjing 210002, China
2. Department of Obstetrics and Gynecology, Jinling Hospital, Nanjing Medical University, Nanjing 210002, China
3. Department of Obstetrics and Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Download:

HTML( 5 )

PDF(1091KB)
Export: BibTeX | EndNote (RIS)

Abstract

Objective: To investigate the relationship of group B streptococcus (GBS) colonization in late pregnancy with perinatal outcome. Methods: Pregnant women who underwent antenatal check-up at General Hospital of PLA Eastern Theater Command and the First Affiliated Hospital of Nanjing Medical University from January 2016 to December 2018 were enrolled in the study. The vaginal and rectal swab samples were collected for GBS culture at 35-37 weeks of pregnancy. The perinatal outcomes of positive and negative GBS groups were compared. The GBS-positive group samples were tested for antibiotic susceptibility. In GBS positive group the maternal and child perinatal outcomes were compared between pregnant women with antibiotics treatment and those without antibiotics. Results: A total of 13 000 pregnant women were enrolled, and the overall colonization rate of GBS was 3.65%(475/13 000). The colonization rate of GBS in the vagina was 2.33%(303/13 000), and the colonization rate in the rectum was 1.75%(227/13 000). Through the collection and detection of rectal specimens, the positive rate of GBS increased by 56.77%(172/303). The monthly colonization rate of GBS showed significant fluctuations with the highest in March and October (all P < 0.05). The sensitivity of 475 GBS-positive specimens to ceftriaxone, vancomycin and linezolid were 100%, and the sensitivity to ampicillin and penicillin were 97.26%and 93.47%, respectively. The resistance rates of the strains to levofloxacin, clindamycin, erythromycin and tetracycline were 30.11%, 48.00%, 52.21%and 88.63%. The incidence of premature rupture of membranes, postpartum hemorrhage, puerperal infection, neonatal pneumonia and sepsis in GBS positive group were significantly higher than those in GBS negative group (all P < 0.01). In pregnant women with positive GBS, the incidence of puerperal infection, neonatal infection and admission to the NICU in the antibiotic group were significantly lower than those in the non-antibiotic group (P < 0.05 or P < 0.01). Conclusions: The total colonization rate of GBS is low. The detection of GBS can be significantly improved by supplementing rectal examination. Ceftriaxone, ampicillin and penicillin are currently the drugs of choice for the prevention and treatment of GBS-related diseases. GBS infection can increase the incidence of maternal and child complications. The use of antibiotics during labor can improve the outcome of mothers and infants.

Key words： Pregnancy trimester, third Streptococcus agalactiae Anti-bacterial agents Microbial sensitivity tests Pregnancy outcome Perinatology Vagina/microbiology Rectum/microbiology

Received: 20 August 2019 Published: 16 April 2020

CLC:

R714.1

Corresponding Authors: SUN Lizhou E-mail: yanglingdong-123@163.com;lizhou_sun@163.com

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YANG Lindong
	BAO Fang
	WU Yuanzhe
	SUN Lizhou

Cite this article:

YANG Lindong,BAO Fang,WU Yuanzhe,SUN Lizhou. Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes. J Zhejiang Univ (Med Sci), 2020, 49(3): 389-396.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2020.04.12 OR http://www.zjujournals.com/med/Y2020/V49/I3/389

晚期妊娠孕妇B群链球菌定植状况及妊娠结局分析

目的: 探讨妊娠晚期孕妇B群链球菌（GBS）定植情况、抗菌药物敏感性及妊娠结局。方法: 纳入2016年1月至2018年12月在东部战区总医院和南京医科大学第一附属医院妇产科定期产检的孕妇，于孕35~37周采用标准方法采集阴道及直肠拭子进行GBS培养，并对阳性标本分离的菌株进行药物敏感性试验。按培养结果分为GBS阳性组和GBS阴性组，阳性组按照产程中是否使用了抗菌药物治疗分为用药组与未用药组，比较不同组别妊娠结局的差异。结果: 共13 000名孕妇入组，GBS总体定植率为3.65%（475/13 000）。GBS在阴道中定植率为2.33%（303/13 000），在直肠中定植率为1.75%（227/13 000）。通过对直肠标本的采集检测，GBS阳性检出率增加了56.77%（172/303）。GBS每月的定植率有明显波动，3月份和10月份最高（均P < 0.05）。475份GBS阳性标本对头孢曲松、万古霉素和利奈唑胺的敏感率为100%，对氨苄西林和青霉素的敏感率分别为97.26%和93.47%，而对左氧氟沙星、克林霉素、红霉素、四环素的耐药率较高，分别为30.11%、48.00%、52.21%和88.63%。GBS阳性组胎膜早破、产后出血、产褥期感染、新生儿肺炎、败血症发生率较GBS阴性组明显增高（均P < 0.01）。产程中预防性使用抗菌药物的GBS阳性孕妇产褥期感染、新生儿感染及新生儿重症监护室入住率明显低于未使用抗菌药物的孕妇（P < 0.05或P < 0.01）。结论: 妊娠晚期孕妇GBS定植率较低，无明显的季节性，通过补充直肠检测能提高GBS检出率。头孢曲松、氨苄西林和青霉素是目前预防和治疗GBS相关疾病的首选药物。GBS感染会明显增加母婴并发症的发生可能，产程中抗菌药物治疗可以改善母婴的结局。

关键词： 妊娠末期, 无乳链球菌, 抗菌药, 微生物敏感性试验, 妊娠结局, 围生医学, 阴道/微生物学, 直肠/微生物学

Tab 1 The colonization of group B streptococcus in vagina and rectum of 13 000 women with late pregnancy

Fig 1 Group B streptococcus (GBS) colonization rate fluctuations during 2016 to 2018

Tab 2 Antibiotic susceptibility of group B streptococcus

[n(%)]

Tab 3 Comparison of basic conditions between group B streptococcus (GBS) positive women and GBS-negative women [$\bar x \pm s$或n(%)]

Tab 4 Comparison of pregnancy outcome between group B streptococcus (GBS) positive women and GBS-negative women [n(%)]

Tab 5 Comparison of basic conditions and pregnancy outcome between group B streptococcus positive women received antibiotics treatment or not [$\bar x \pm s$或n(%)]


[1]	EICKHOFF T C , KLEIN J O , DALY A K et al. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci[J]. N Engl J Med, 1964, 271 1221- 1228 doi: 10.1056/NEJM196412102712401

[2]	LE DOARE K , HEATH P T . An overview of global GBS epidemiology[J]. Vaccine, 2013, 31 (Suppl 4): D7- D12 doi: 10.1016/j.vaccine.2013.01.009

[3]	EDMOND K M , KORTSALIOUDAKI C , SCOTT S et al. Group B streptococcal disease in infants aged younger than 3 months:systematic review and meta-analysis[J]. Lancet, 2012, 379 (9815): 547- 556 doi: 10.1016/S0140-6736(11)61651-6

[4]	VERANI J R , MCGEE L , SCHRAG S J et al. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59 (RR-10): 1- 36

[5]	CHEN V L , AVCI F Y , KASPER D L . A maternal vaccine against group B streptococcus:past, present, and future[J]. Vaccine, 2013, 31 (Suppl 4): D13- D19 doi: 10.1016/j.vaccine.2012.12.080

[6]	Clinical and Laboratory Standards Institute. M100-S22 Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement[S]. Wayne, PA: Clinical and Laboratory Standards Institute, 2012.

[7]	JOHRI A K , LATA H , YADAV P et al. Epidemiology of group B streptococcus in developing countries[J]. Vaccine, 2013, 31 (Suppl 4): D43- D45 doi: 10.1016/j.vaccine.2013.05.094

[8]	KWATRA G , CUNNINGTON M C , MERRALL E et al. Prevalence of maternal colonisation with group B streptococcus:a systematic review and meta-analysis[J]. Lancet Infect Dis, 2016, 16 (9): 1076- 1084 doi: 10.1016/S1473-3099(16)30055-X

[9]	CHO C Y , TANG Y H , CHENY H et al. Group B Streptococcal infection in neonates and colonization in pregnant women:An epidemiological retrospective analysis[J]. J Microbiol Immunol Infect, 2019, 52 (2): 265- 272 doi: 10.1016/j.jmii.2017.08.004

[10]	LU B , LI D , CUI Y et al. Epidemiology of group B streptococcus isolated from pregnant women in Beijing, China[J]. Clin Microbiol Infect, 2014, 20 (6): O370- O373 doi: 10.1111/1469-0691.12416

[11]	JI W, ZHANG L, GUO Z, et al. Colonization prevalence and antibiotic susceptibility of group B streptococcus in pregnant women over a 6-year period in Dongguan, China[J/OL]. PLoS One, 2017, 12(8): e0183083. DOI: 10.1371/journal.pone.0183083.

[12]	时春艳, 曲首辉, 杨磊 et al. 妊娠晚期孕妇B族链球菌带菌状况的检测及带菌对妊娠结局的影响[J]. 中华妇产科杂志, 2010, 45 (1): 12- 16 SHI Chunyan , QU Shouhui , YANG Lei et al. Detection of maternal colonization of group B streptococcus in late pregnancy by real-time polymerase chain reaction and its effect on perinatal outcome[J]. Chinese Journal of Obstetrics and Gynecology, 2010, 45 (1): 12- 16 doi: 10.3760/cma.j.issn.0529-567x.2010.01.005

[13]	RICK A M , AGUILAR A , CORTES R et al. Group B streptococci colonization in pregnant guatemalan women:prevalence, risk factors, and vaginal microbiome[J]. Open Forum Infect Dis, 2017, 4 (1): ofx020 doi: 10.1093/ofid/ofx020

[14]	PHILIPSON E H , PALERMINO D A , ROBINSON A . Enhanced antenatal detection of group B streptococcus colonization[J]. Obstet Gynecol, 1995, 85 (3): 437- 439 doi: 10.1016/0029-7844(94)00412-7

[15]	KOVAVISARACH E , SA-ADYING W , KANJANAHAREUTAI S . Comparison of combined vaginal-anorectal, vaginal and anorectal cultures in detecting of group B streptococci in pregnant women in labor[J]. J Med Assoc Thai, 2007, 90 (9): 1710- 1714

[16]	MA Y Y , HSU T Y , SHEN S Y et al. Epidemiology of group B streptococcus ST-17 clone in pregnant women of South Taiwan[J]. Gynecol Obstet Invest, 2012, 73 (4): 285- 293 doi: 10.1159/000334406

[17]	林新祝, 吴健宁, 张雪芹 et al. 晚孕期阴道B族链球菌定植与新生儿感染的关系[J]. 中华围产医学杂志, 2016, 19 (7): 491- 496 LIN Xinzhu , WU Jianning , ZHANG Xueqin et al. Relationship between group B streptococcus colonization in late pregnancies and neonatal infection[J]. Chinese Journal of Perinatal Medicine, 2016, 19 (7): 491- 496 doi: 10.3760/cma.j.issn.1007-9408.2016.07.003

[18]	PHARES C R , LYNFIELD R , FARLEY M M et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005[J]. JAMA, 2008, 299 (17): 2056- 2065 doi: 10.1001/jama.299.17.2056

[19]	DE AZAVEDO J C , MCGAVIN M , DUNCANC et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada[J]. Antimicrob Agents Chemother, 2001, 45 (12): 3504- 3508 doi: 10.1128/AAC.45.12.3504-3508.2001

[20]	MORIKAWA Y , KITAZATO M , KATSUKAWA C et al. Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan[J]. J Infect Chemother, 2003, 9 (2): 131- 133 doi: 10.1007/s10156-002-0230-6

[21]	沈铿, 马丁, 狄文 et al. 妇产科学[M]. 3版, 北京: 人民卫生出版社, 2015: 164- 166 SHEN Keng , MA Ding , DI Wen et al. Obstetrics and gynecology[M]. 3rd ed, Beijing: People's Medical Publishing House, 2015: 164- 166

[22]	BARCAITE E , BARTUSEVICIUS A , TAMELIENE R et al. Prevalence of maternal group B streptococcal colonisation in European countries[J]. Acta Obstet Gynecol Scand, 2008, 87 (3): 260- 271 doi: 10.1080/00016340801908759

[23]	GHADDAR N , ALFOUZAN W , ANASTASIADIS E et al. Evaluation of chromogenic medium and direct latex agglutination test for detection of group B streptococcus in vaginal specimens from pregnant women in Lebanon and Kuwait[J]. J Med Microbiol, 2014, 63 (Pt 10): 1395- 1399 doi: 10.1099/jmm.0.066738-0

[24]	ARMISTEAD B , OLER E , ADAMS WALDORF K et al. The double life of group B streptococcus:asymptomatic colonizer and potent pathogen[J]. J Mol Biol, 2019, 431 (16): 2914- 2931 doi: 10.1016/j.jmb.2019.01.035

[25]	BAKER C J . The spectrum of perinatal group B streptococcal disease[J]. Vaccine, 2013, 31 (Suppl 4): D3- D6 doi: 10.1016/j.vaccine.2013.02.030

[26]	GARVY B A , HARMSEN A G . The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice[J]. Inflammation, 1996, 20 (5): 499- 512 doi: 10.1007/bf01487042

[27]	STOLL B J , HANSEN N I , SáNCHEZP J et al. Early onset neonatal sepsis:the burden of group B streptococcal and E. coli disease continues[J]. Pediatrics, 2011, 127 (5): 817- 826 doi: 10.1542/peds.2010-2217

[28]	邓江红, 姚开虎, 胡惠丽 et al. 新生儿肺炎死亡病例中B族链球菌的检测[J]. 中华儿科杂志, 2006, 44 (11): 850- 854 DENG Jianghong , YAO Kaihu , HU Huili et al. Detection of group B streptococcus in the cases died of neonatal pneumonia[J]. Chinese Journal of Pediatrics, 2006, 44 (11): 850- 854 doi: 10.3760/j.issn:0578-1310.2006.11.015

[1]	CHEN Xu,LI Yang,WANG Jinxi,CAI Hongliu,CAO Hongcui,SHENG Jifang. Pregnant women complicated with COVID-19: a clinical analysis of 3 cases[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 240-244.

[2]	LIN Xiaoxiao,SUN Daifei,FU Jun,ZHONG Huizhen. Outcome of re-pregnancy in women with uterine artery embolization for postpartum hemorrhage[J]. J Zhejiang Univ (Med Sci), 2019, 48(5): 540-545.

[3]	MEI Jin,LIU Jiao,WANG Min,ZHANG Wen,WANG Hao,LU Sha,HE Chaying,JIN Chunlei. Prenatal diagnosis and pregnancy outcomes of 22q11.2 duplication syndrome: analysis of 8 cases[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 429-433.

[4]	SUN Ting,XU Mingjuan. Body weight and gestational outcomes in women with high normotension during pregnancy[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 174-179.

[5]	SHI Jing,FENG Jue. New inhibitors targeting bacterial RNA polymerase[J]. J Zhejiang Univ (Med Sci), 2019, 48(1): 44-49.

[6]	PENG Dandan,ZHOU Xudong. Parents' antibiotic use for children in Ningbo: knowledge, behaviors and influencing factors[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 156-162.

[7]	LI Enshu, YE Xiaoqun, FANG Li, YE Yinghui. *Effect of oxygen concentration on outcome of in-vitro* fertilization-embryo transfer**[J]. J Zhejiang Univ (Med Sci), 2017, 46(3): 290-294.

[8]	SHI Biwei, CUI Long, YE Xiaoqun, YE Yinghui. Effects of embryo cryopreservation and thawing on clinical outcomes of transplantable embryos after cleavage-stage preimplantation genetic diagnosis or screening[J]. J Zhejiang Univ (Med Sci), 2017, 46(3): 295-299.

[9]	ZHANG Jian-zhen, HE Jing. Risk factors of recurrent preeclampsia and its relation to maternal and offspring outcome[J]. J Zhejiang Univ (Med Sci), 2015, 44(3): 258-263.

[10]	SHEN Qin-qin, ZHANG Tan. Research advances on prenatal maternal serum markers for screening adverse pregnancy outcomes[J]. J Zhejiang Univ (Med Sci), 2015, 44(3): 339-343.

[11]	ZHANG Jie, LI Xiu-Juan. Biological characteristics of phage SM1 for Stenotrophomonas maltophilia and its effect in animal infection model[J]. J Zhejiang Univ (Med Sci), 2013, 42(3): 331-336.

[12]	LI Miao, ZHU Yi-Min . Impact of hepatitis B virus on sperm parameters and outcome of assisted reproductive technology[J]. J Zhejiang Univ (Med Sci), 2013, 42(2): 237-241.

[13]	. Serial recombinant expression and anti-tumor activity in vitro of antibiotic peptide Alloferon-1[J]. J Zhejiang Univ (Med Sci), 2011, 40(5): 501-507.

Viewed

Full text

Abstract

Cited

Shared

Discussed